Persistent Supravenous Erythematous Eruption (PSEE): A scoping review on an adverse effect related to Docetaxel infusion
DOI:
https://doi.org/10.33448/rsd-v11i5.27974Keywords:
Antineoplastics; Toxicity; Nursing oncology; Docetaxel.Abstract
Objectives: To identify and synthesize scientific evidence about Persistent Supravenous Erythematous Eruption (PSEE), in order to characterize it and provide support to clinical practice in differentiating this event from Docetaxel extravasation. Methods: scoping review, according to Joanna Briggs Institute. The PCC strategy was used to formulate the research question. Research was carried out in four electronic databases: PubMed, Embase, CINAHL and VHL/IBECS. Data collection took place from February to May 2021, aiming at a time frame of the last 10 years. The data extracted from the selected articles were analyzed and synthesized in a narrative way. Results: a total of 474 records were retrieved and 7 studies were kept for review. Most of the publications (4) were of the case report type, being possible to have the main information, extracted, in the form of tables and categorization of these in: Possible causes of PSEE; PSEE pathophysiology; Frame characterization; Prevention measures; Management of PSEE. Conclusions: Evidence raised about PSEE allowed its characterization and differentiation in relation to extravasation, with the possibility of guiding correct management and more assertive care of nursing and other components of the health team to a toxicity inherent to the chemotherapy treatment.
References
Ascherman, J. A., Knowles, S. L., & Attkiss, K. (2000). Docetaxel (taxotere) extravasation: a report of five cases with treatment recommendations. Annals of Plastic Surgery, 45(4), 438–441.
Cifuentes, L., Ring, J., & Brockow, K. (2012). Extravasation of docetaxel. Journal of the German Society of Dermatology, 10(9), 662–663.
Cury-Martins, J., Eris, A. P. M., Abdalla, C. M. Z., Silva, G. de B., Moura, V. P. T. de, & Sanches, J. A. (2020). Manejo dos eventos adversos dermatológicos das terapias cológicas: de um painel de especialistas em especialistas. Anais Brasileiros de Dermatologia, 95(2), 221–237.
Das, A., Kumar, D., Mohanty, S., Mondal, A. K., Chowdhury, S. N., & Bandyopadhyay, D. (2015). Serpentine supravenous hyperpigmentation induced by docetaxel. Indian Journal of Dermatology, Venereology and Leprology, 81(4), 434-436.
Docetaxel [bula]. (2015). Solução concentrada para infusão. Responsável técnico Cintia Delphino de Andrade. São Paulo: Libbs Farmacêutica. DOCE_v.15-15.
Donati, A. & Castro, L. G. M. (2011). Efeitos colaterais cutâneos de quimioterapia com taxanos: O ponto de vista do dermatologista. Anais Brasileiros de Dermatologia, 86(4), 755-758.
Elm’hadi, C., Tanz, R., Khmamouche, M. R., Toreis, M., Mahfoud, T., Slimani, K. A., ... & Ichou, M. (2016). Toxicities of docetaxel: original drug versus generics—a comparative study about 81 cases. SpringerPlus, 5(1), 1-7.
Faria, L. P. & Fagundes, T. R. (2020). Chemotherapic extravasation: the nurse’s role in oncological emergency. Research, Society and Development, 9(10), e9719109400.
Fernandes, K. P. & Felix, P. A. (2015). Erupção eritematosa supravenosa induzida por docetaxel persistente. Anais Brasileiro de Dermatologia, 90(5), 728-730.
Freitas, K. A. B. S. (2015). Estratégias para administração segura de antineoplásicos (Dissertação de Mestrado). Universidade Estadual Paulista Júlio de Mesquita Filho, Botucatu, Brasil.
Fuchs, F. D. & Wannmacher, L. (2017). Farmacologia clínica e terapêutica. São Paulo, SP: Grupo Gen-Guanabara Koogan.
Ghosh, S. K., Bandyopadhyay, D., Ghosh, L., & Basu, S. (2011). Docetaxel-induced supravenous serpentine dermatitis. Dermatology Online Journal, 17(11), s.p.
González-Haba-Peña, E., Garrido-Siles, M., Martínez-Bautista, M. J., Burgos-San-José, A., Aldaz-Pastor, A., & Mangues-Bafalluy, I. (2020). Estudio observacional de la toxicidad con diferentes formulaciones de docetaxel en pacientes con cáncer de mama. Farmacia Hospitalaria, 44(5), 192-197.
Guimarães, R. D. C. R., Gonçalves, R. P. F., de Almeida Lima, C., Torres, M. R., & de Oliveira, C. S. (2015). Ações de enfermagem frente às reações a quimioterápicos em pacientes oncológicos. Revista de Pesquisa Cuidado é Fundamental online, 7(2), 2440-2452.
Haba-Peña, E. G., Garrido-Siles, M., Martínez-Bautista, M. J., Burgos-San-José, A., Aldaz-Pastor, A., & Mangues-Bafalluy, I. (2020). Estudio observacional de la toxicidad con diferentes formulaciones de docetaxel en pacientes con cáncer de mama. Farmacia Hospitalaria, 44(5), 192-197.
Ho, C. H., Yang, C. H., & Chu, C. Y. (2003). Vesicant-type reaction due to docetaxel extravasation. Acta Dermato-venereologica, 83(6), 467-468.
Jackson-Rose, J., Groman, A., Dial, L. S., Atwell, L. N., Graham, J., Semler, R. O. N., ... & West, C. (2017). Chemotherapy Extravasation: establishing a national benchmark for incidence among Cancer Centers. Clinical Journal of Oncology Nursing, 21(4), 438-445.
Lancman, G., Steinberg, A., & Gabrilove, J. (2018). Serpentine Supravenous Hyperpigmentation in an HIV Patient Receiving R-CHOP for DLBCL. International Journal of Hematology-Oncology and Stem Cell Research, 12, 1-3.
Fidalgo, J. P., Fabregat, L. G., Cervantes, A., Margulies, A., Vidall, C., & Roila, F. (2012). Management of chemotherapy extravasation: ESMO–EONS clinical practice guidelines. European Journal of Oncology Nursing, 16(5), 528-534.
Sibaud, V., Lebœuf, N. R., Roche, H. Belum, V. R., Gladieff, L., Deslandres, M., ... & Lacouture, M. E. (2016). Dermatological adverse events with taxane chemotherapy. European Journal of Dermatology, 26(5), 427–443.
Souza, F. D. S. L., Abreu, A. C. S., Pio, D. A., Sanglard, H. M. D. P. V., & dos Santos, N. A. R. (2019). Cuidados de enfermagem ao paciente oncológico em tratamento quimioterápico ambulatorial. Revista Eletrônica Acervo Saúde, (31), e838.
Souza, F. (2020). Prevalência e manifestações clínicas de Neuropatia Periférica Induzida por Quimioterapia (NPIQ) em pacientes submetidos ao tratamento oncológico em um hospital escola de Florianópolis (Dissertação de Mestrado). Universidade Federal de Santa Catarina, Florianópolis, Brasil.
Zhu, J. J., Fu, J. F., Yang, J., Hu, B., Zhang, H., & Yu, J. H. (2014). Rat injury model of docetaxel extravasation. Biomedical Reports, 2(5), 649–652.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Aurilio Sergio Araujo Viana; Lívia Márcia Vidal Pires
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
